Lihui Wang

3.3k total citations
95 papers, 2.6k citations indexed

About

Lihui Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lihui Wang has authored 95 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Lihui Wang's work include Epigenetics and DNA Methylation (23 papers), Histone Deacetylase Inhibitors Research (15 papers) and RNA modifications and cancer (12 papers). Lihui Wang is often cited by papers focused on Epigenetics and DNA Methylation (23 papers), Histone Deacetylase Inhibitors Research (15 papers) and RNA modifications and cancer (12 papers). Lihui Wang collaborates with scholars based in China, United States and South Korea. Lihui Wang's co-authors include Chunfu Wu, Jingyu Yang, Wei Cui, Jiayu Zhang, Cheng Yang, Yanhua Mou, Guoliang Chen, Ping Gong, Lina Jia and Xing Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nano Letters and The Journal of Physical Chemistry B.

In The Last Decade

Lihui Wang

92 papers receiving 2.5k citations

Peers

Lihui Wang
Bruno Perillo Italy
Yanan Liu China
Barbara Marengo Italy
Antonio Pezone Italy
Anna Lisa Furfaro Italy
Hyo Jin Kang South Korea
Giovanni Galasso Italy
Marcia A. Ogasawara United States
Nasser Samadi Iran
Bruno Perillo Italy
Lihui Wang
Citations per year, relative to Lihui Wang Lihui Wang (= 1×) peers Bruno Perillo

Countries citing papers authored by Lihui Wang

Since Specialization
Citations

This map shows the geographic impact of Lihui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Wang more than expected).

Fields of papers citing papers by Lihui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Wang. The network helps show where Lihui Wang may publish in the future.

Co-authorship network of co-authors of Lihui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Wang. A scholar is included among the top collaborators of Lihui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Wang. Lihui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Ming, Xiaoyuan Wang, Yongshan Zhao, et al.. (2025). Activation of epigenetic reprogramming via crotonylation overcomes resistance to EGFR-TKI therapy in lung cancer. Proceedings of the National Academy of Sciences. 122(40). e2509255122–e2509255122. 1 indexed citations
2.
Xu, Jian‐Guang, et al.. (2025). Nav1.6 drives colorectal cancer proliferation and invasion through MAPK signaling pathway. World Journal of Gastrointestinal Oncology. 17(7). 105264–105264. 1 indexed citations
3.
Yang, Cheng, Jie Zhang, Yuchen Han, et al.. (2024). EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer. Proceedings of the National Academy of Sciences. 121(23). e2317790121–e2317790121. 11 indexed citations
4.
Liu, Shuyu, et al.. (2024). Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy. Journal of Medicinal Chemistry. 67(18). 16248–16269. 1 indexed citations
5.
Yang, Yuan, Yidong Wang, Jiwei Gao, et al.. (2024). The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO Molecular Medicine. 16(4). 885–903. 5 indexed citations
6.
Cao, Zhi, Shuyu Liu, Jiahao Zhang, et al.. (2024). Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer. Acta Pharmaceutica Sinica B. 14(8). 3605–3623. 3 indexed citations
7.
Wang, Jianmin, Yang Du, Lu Chen, et al.. (2023). Design, synthesis and evaluation of the novel chalcone derivatives with 2,2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential. European Journal of Medicinal Chemistry. 250. 115171–115171. 4 indexed citations
8.
Chen, Yongyang, Xiaobi Huang, Lihui Wang, et al.. (2023). Circular RNA‐mediated ceRNA network was identified in human lung adenocarcinoma by high‐throughput sequencing. Thoracic Cancer. 14(16). 1430–1439. 4 indexed citations
9.
Han, Mei, Xiaoxuan Wang, Weiming Yang, et al.. (2023). Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway. Science Advances. 9(22). eadc9273–eadc9273. 12 indexed citations
10.
Wang, Zhiguo, et al.. (2022). Molecular mechanism of anionic stabilizer for telomere G-quadruplex. Biophysics Reports. 8(4). 225–238. 2 indexed citations
11.
Wang, Wenjing, Jianmin Wang, Shuai Liu, et al.. (2022). An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer. Molecular Cancer. 21(1). 106–106. 43 indexed citations
12.
Wang, Wenjing, Mengyue Zhao, Lijuan Cui, et al.. (2020). Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer. Molecular Cancer. 19(1). 134–134. 57 indexed citations
13.
Ni, Guohua, Ling Mao, Jijie Zhang, et al.. (2019). <p>LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis</p>. OncoTargets and Therapy. Volume 12. 7865–7875. 21 indexed citations
14.
Wang, Lihui, et al.. (2017). Clinical effects of α-lipoic acid combined with epalrestat in elderly patients with diabetic peripheral neuropathy. Zhonghua laonian yixue zazhi. 36(3). 287–291. 1 indexed citations
15.
Zhang, Jie, Wenmei Su, Lei Xiao, et al.. (2017). Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Scientific Reports. 7(1). 42819–42819. 43 indexed citations
16.
Liu, Zijian, Shasha Wu, Yu Wang, et al.. (2014). Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents. European Journal of Medicinal Chemistry. 87. 782–793. 67 indexed citations
17.
Cui, Wei, Lihui Wang, Yuanyuan Wen, et al.. (2010). Expression and regulation mechanisms of Sonic Hedgehog in breast cancer. Cancer Science. 101(4). 927–933. 76 indexed citations
18.
19.
Lee, Jung Hyun, Seok-Hyung Kim, Lihui Wang, et al.. (2007). Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma. Clinical Cancer Research. 13(9). 2584–2591. 26 indexed citations
20.
Wang, Lihui, Jung Hyun Lee, Yoon‐La Choi, et al.. (2007). Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression. Clinical Cancer Research. 13(1). 102–110. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Perillo Breakdown of academic impact, for papers by Yanan Liu Breakdown of academic impact, for papers by Barbara Marengo Breakdown of academic impact, for papers by Antonio Pezone Breakdown of academic impact, for papers by Anna Lisa Furfaro Breakdown of academic impact, for papers by Hyo Jin Kang Breakdown of academic impact, for papers by Giovanni Galasso Breakdown of academic impact, for papers by Marcia A. Ogasawara Breakdown of academic impact, for papers by Nasser Samadi
Rankless by CCL
2026